agilon health, inc.
AGL
$2.97
$0.082.77%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 9.69% | -5.82% | -435.33% | -319.92% | -191.99% |
| Total Depreciation and Amortization | 73.98% | 88.19% | 208.98% | 205.83% | 50.07% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -79.13% | -45.88% | 312.50% | 235.91% | 170.76% |
| Change in Net Operating Assets | 302.36% | 1,153.25% | 241.67% | 146.52% | 131.96% |
| Cash from Operations | 70.67% | 63.01% | 6.64% | -8.78% | 14.98% |
| Capital Expenditure | -25.12% | -12.91% | -23.24% | -36.01% | 26.08% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | 98.26% | 98.01% | 98.01% |
| Divestitures | -- | -- | -- | -- | 338.60% |
| Other Investing Activities | 65.09% | 1,754.52% | 1,000.70% | 151.65% | 111.24% |
| Cash from Investing | 12.25% | 417.80% | 329.01% | 133.25% | 111.97% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 33.33% | 0.00% | -33.33% | -33.33% | 25.00% |
| Issuance of Common Stock | -- | -85.70% | -84.87% | -78.17% | -82.52% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 98.36% | 98.66% | 98.22% | 99.68% | -977.77% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 107.02% | 120.22% | 93.59% | 82.41% | 54.76% |